- Presentations
- 3
- Markets
- 1
Tremfya is a brand of Guselkumab marketed by Janssen Biotech, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Guselkumab
- Brand owner
- Janssen Biotech
- Registered in
- United States
- Strengths and forms
- 100 mg/1 mL injection, 200 mg/2 mL injection, 200 mg/20 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tremfya 100 mg/1 mL injectionSubcutaneous Cold chain | Janssen Biotech | US FDA | Available on request |
| Tremfya 200 mg/2 mL injectionSubcutaneous Cold chain | Janssen Biotech | US FDA | Available on request |
| Tremfya 200 mg/20 mL injectionIntravenous Cold chain | Janssen Biotech | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tremfya
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.